The three papers in this symposium may appear on first reading to be concerned with just a single piece of biomedical research - the recombinant DNA technique and its technological offspring now known familiarly, and in the long-run perhaps regrettably, as "genetic engineering." Two possible applications of the technology are the primary sources of public worry: 1) the risks entailed in a purposeful release into the environment of genetically altered species, for one or another commendable and profitable use, and 2) the hazard in any purposeful correction of a genetic abnormality in human beings.
Regulating Biotechnology: Introduction,
Yale L. & Pol'y Rev.
Available at: https://digitalcommons.law.yale.edu/ylpr/vol3/iss2/2